Cipla is looking at the whole GLP-1 category and not just Semaglutide alone, says Cipla CEO Umang Vohra in a post-results ...

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

For years, Elyse Schroeder had a secret routine. She would wake up with constant thoughts of food playing on loop in her mind ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...